| PRD_002367 | Name: | ~{N}-[3-[3-(dimethylamino)propylamino]-3-oxidanylidene-propyl]-1-methyl-4-[3-[[1-methyl-4-[[1-methyl-4-[3-[[1-methyl-4-[(1-methylimidazol-2-yl)carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazol-2-yl]carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazole-2-carboxamide | Formula: | C41 H55 N17 O8 | Definition date: | 2022-08-03 | Last modified: | 2022-08-03 |
|
| PRD_002384 | Formula: | C58 H95 N15 O15 | Definition date: | 2022-08-03 | Last modified: | 2022-08-03 |
|
| PRD_000468 | Name: | Allosamidin | Formula: | C25 H42 N4 O14 | Definition date: | 2015-07-18 | Last modified: | 2022-03-03 |
|
| PRD_002479 | Name: | Cyclic Peptide Inhibitor ZO1-GLN-SER-TPO-45W-MLL | Formula: | C34 H48 F3 N6 O14 P | Definition date: | 2022-03-02 | Last modified: | 2022-03-02 |
|
| PRD_000204 | Name: | Vancomycin | Formula: | C66 H75 Cl2 N9 O24 | Description: | VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY A DISACCHARIDE (RESIDUES 8 AND 9) ON RESIDUE 4. | Definition date: | 2012-12-12 | Last modified: | 2022-01-06 |
|
| PRD_002455 | Name: | D-PMI-omega | Formula: | C82 H115 Cl N17 O20 | Definition date: | 2021-11-17 | Last modified: | 2021-11-17 |
|
| PRD_002454 | Name: | Substrate-like cysteine protease inhibitor | Formula: | C46 H70 Cl N10 O9 | Definition date: | 2021-09-01 | Last modified: | 2021-09-01 |
|
| PRD_002469 | Name: | Inhibitor 18 | Formula: | C30 H42 N4 O6 | Definition date: | 2021-08-25 | Last modified: | 2021-08-25 |
|
| PRD_002457 | Name: | beta-D-glucopyranose-(1-4)-beta-D-glucopyranose-(1-3)-2-deoxy-2-fluoro-alpha-D-glucopyranose | Formula: | C18 H31 F O15 | Definition date: | 2021-05-19 | Last modified: | 2021-05-19 |
|
| PRD_002383 | Name: | des4.3.1 | Formula: | C44 H74 N12 O11 S | Definition date: | 2021-04-28 | Last modified: | 2021-04-28 |
|
| PRD_002362 | Name: | GsIN-1 peptide | Formula: | C79 H106 N16 O21 S | Definition date: | 2021-04-21 | Last modified: | 2021-04-21 |
|
| PRD_002397 | Formula: | C41 H72 N14 O10 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
| PRD_002398 | Formula: | C42 H74 N14 O10 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
| PRD_002399 | Formula: | C45 H68 N10 O11 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
| PRD_002360 | Name: | myristoyl thiourea inhibitor, No. 23 | Formula: | C37 H67 N9 O5 S | Definition date: | 2021-03-24 | Last modified: | 2021-03-24 |
|
| PRD_002361 | Name: | myristoyl thiourea inhibitor, No.13 | Formula: | C39 H73 N12 O5 S | Definition date: | 2021-03-24 | Last modified: | 2021-03-24 |
|
| PRD_002460 | Formula: | C20 H39 N3 O5 | Description: | Calpain I inhibitor | Definition date: | 2021-02-24 | Last modified: | 2021-02-24 |
|
| PRD_900134 | Name: | Blood group B H type 2 antigen, beta anomer | Formula: | C26 H45 N O20 | Description: | oligosaccharide with branches | Definition date: | 2021-02-17 | Last modified: | 2021-02-17 |
|
| PRD_002447 | Name: | (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide | Formula: | C36 H55 N7 O6 | Definition date: | 2020-10-07 | Last modified: | 2020-10-14 |
|
| PRD_002448 | Name: | (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide | Formula: | C36 H55 N7 O6 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
| PRD_002449 | Name: | (ACE)(1MH)D(B3L)F(1U8) | Formula: | C44 H54 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
| PRD_002450 | Name: | (ACE)(1MH)D(PF5)F(1U8) | Formula: | C46 H45 F5 N6 O12 | Definition date: | 2020-09-30 | Last modified: | 2020-09-30 |
|
| PRD_002372 | Name: | ACE-VAL-ARG-MET-QZA | Formula: | C22 H43 Cl N7 O5 S | Definition date: | 2020-09-16 | Last modified: | 2020-09-16 |
|
| PRD_002373 | Name: | ACE-VAL-ARG-MET-B2A | Formula: | C20 H41 B N7 O6 S | Definition date: | 2020-09-16 | Last modified: | 2020-09-16 |
|
| PRD_002352 | Formula: | C22 H31 N3 O7 | Definition date: | 2020-09-02 | Last modified: | 2020-09-02 |
|